Migraine and Function of the Immune System: A Meta-Analysis of Clinical Literature Published Between 1966 and 1999

Abstract

Mechanisms underlying migraine precipitation are largely unknown. A role of the immune system in migraine precipitation is a matter of debate because of the association of atopic disorders and migraine. Recently, it was demonstrated that migraineurs benefit from eradication of a Helicobacter pylori infection, which substantiates a possible role for (sub-clinical) infections in precipitation of migraine. Since 1966, about 45 clinical investigations have reported on alterations of immune function in migraine patients, which we present in this review. Changes of serum levels of complement and immunoglobulins, histamine, cytokines and immune cells were found in some of these studies but in most cases not corroborated by others. Migraineurs suffering from comorbid atopic disorders show elevated plasma IgE levels but not patients without a type I hypersensitivity. Histamine plasma levels are chronically elevated in migraineurs, and interictally decreased lymphocyte phagocytotic function and increased plasma tumor necrosis factor alpha (TNFalpha) levels were found, and may be related to increased infection susceptibility. The cause of this increased susceptibility is unclear but most likely is a result of chronic stress, a well-known suppressor of the immune system. Stress relief enhances immune activity and triggers a burst of circulating vasoactive compounds that function as mediators of inflammation and potential precipitators of a migraine attack in vulnerable subjects. In conclusion, in the clinical literature of the past decades, there is no clear-cut evidence of an immune dysfunction in migraineurs, but we cannot totally exclude the possibility of an altered immune function in migraineurs. Discrepancies in the literature most likely are caused by the divergent patterns of sample collection relative to the time of the attack. We propose stringent definition of sample collection times for future studies of immune function in migraine patients.

Increased risk of migraine in patients with psoriasis: A Danish nationwide cohort study

“…Indeed, recent research has focused on the link between pain and inflammation, and increased tumor necrosis factor-alfa levels, activation of mitogen-activated protein kinases, and endothelial dysfunction are among inflammatory mechanisms that appear to be shared by psoriasis and migraine. [6][7][8][9][10][11][12]27 Along this line, tumor necrosis factor-alfa inhibition may inhibit pain signaling in experimental arthritis and ameliorate endothelial dysfunction in those with psoriasis and psoriatic arthritis, suggesting the potential for targeted anti-inflammatory pharmacologic therapy in the treatment of migraine. [28][29][30] Only very few studies have to our knowledge reported on the association between psoriasis and migraine.…”

The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura

“…TNF-a is able to induce ectopic activity in nociceptive afferent fibers when applied either topically along the nerve or injected subcutaneously [11]. Finally, it has been reported that TNF-a can induce headache and anti-TNF-a antibody can reduce pain in humans [29].…”

Serum Apelin-36 Levels in Migraine Patients with Aura and without Aura

“…Migraine is a chronic disease which affects approximately 12-18% of the society, can be accompanied by neurologic and systemic symptoms, and is characterised by mild or severe recurring headache attacks [1]. The aetiology and pathophysiology of the migraine 77-amino-acid precursor, with an enzymatic reaction.…”